Company Of The Day: Roche

December 6th, 2021 by Trefis Team
+21.74%
Upside
34.50
Market
42.00
Trefis
RHHBY: Roche logo
RHHBY
Roche

What?

Healthcare major Roche (OTMKTS:RHHBY) says that it has developed a new PCR test kit to detect the new omicron variant of the coronavirus, which has been denoted a “variant of concern” by the World Health Organization.

Why?

Relevant Articles
  1. Should You Pick Roche Stock Around $40 After Positive Data For Its Obesity Drugs?
  2. Will Roche Stock Rebound To Its 2022 Highs of $50?
  3. Is Roche Stock Undervalued At $33?
  4. What’s Driving Roche Stock?
  5. Company Of The Day: Roche Holdings
  6. What’s Happening With Roche (RHHBY) Stock?

While widely available Covid-19 tests can detect infections, most tests can’t distinguish between Omicron and other variants. The new test from Roche’s recently acquired subsidiary TIB Molbiol could address this issue.

So What?

While we don’t expect this development to be very material to Roche’s stock, it could enable governments and researchers to better understand the spread and behavior of the concerning new variant.

See Our Complete Analysis For Roche

What if you’re looking for a more balanced portfolio instead? Here’s a high-quality portfolio that’s beaten the market consistently since the end of 2016.

Invest with Trefis Market Beating Portfolios
See all Trefis Price Estimates